# Current Practice and Safety of Invasive Coronary Function Testing: A Nationwide Multicenter Survey in Japan

**Authors:** Takeshi Nishi, Michikazu Nakai, Masanobu Ishii, Tetsuya Matoba, Takashi Muramatsu, Kenichi Tsujita, Ken Kozuma, Yoshio Kobayashi, Shiro Uemura, Koichi Kaikita

PMC · DOI: 10.1016/j.jacadv.2025.102475 · JACC: Advances · 2025-12-22

## TL;DR

This study examines the use and safety of invasive coronary function testing in Japan, finding it to be feasible and safe even in emergency cases.

## Contribution

The study provides the first nationwide assessment of invasive coronary function testing practices and safety in Japan.

## Key findings

- Positivity rates for acetylcholine and ergonovine tests were 50.9% and 32.5%, respectively.
- Major complications were rare, occurring in 1.4% of acetylcholine and 0.4% of ergonovine tests.
- Abnormal microvascular findings were more common in emergency cases compared to elective ones.

## Abstract

Coronary vasomotor dysfunction—including vasospastic angina and coronary microvascular dysfunction—is a key mechanism underlying ischemia or myocardial infarction with nonobstructive coronary arteries (INOCA/MINOCA). While invasive coronary function testing (CFT) provides important diagnostic insights, its real-world use and safety—especially in emergency settings—remain poorly defined.

The purpose of this study was to assess the current practice, diagnostic yield, and safety of CFT, including acetylcholine (ACh) and ergonovine (ERG) provocation tests and coronary microvascular assessments using coronary flow reserve (CFR) and index of microcirculatory resistance (IMR), in Japan.

We conducted a nationwide cross-sectional survey of 235 institutions affiliated with the Japanese Cardiovascular Intervention and Therapeutics Society. Data on procedure volume, positivity rates, and complications were collected for tests performed between January 2022 and December 2023.

Among 6,983 provocation tests, 4,700 were ACh (4,327 elective and 373 emergency) and 2,283 were ERG (2,009 elective and 274 emergency). CFR/IMR was measured in 2,192 cases. Positivity rates were 50.9% for ACh and 32.5% for ERG. Major complications occurred in 1.4% of ACh and 0.4% of ERG tests, with no significant difference between emergency and elective settings. Abnormal CFR/IMR findings were more common in emergency cases (45.9% vs 34.8%; P < 0.001), while complications remained rare (0.05%).

This large-scale survey confirms the feasibility and safety of invasive CFT, even in emergency settings. These findings support its broader adoption in the diagnostic workup of INOCA and MINOCA.

## Linked entities

- **Chemicals:** acetylcholine (PubChem CID 187), ergonovine (PubChem CID 443884)
- **Diseases:** myocardial infarction (MONDO:0005068)

## Full-text entities

- **Diseases:** myocardial infarction (MESH:D009203), MINOCA (MESH:D000088442), coronary microvascular dysfunction (MESH:D003327), ischemia (MESH:D007511), vasospastic angina (MESH:D000787)
- **Chemicals:** ERG (MESH:D004874), ACh (MESH:D000109)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12796537/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12796537/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12796537/full.md

---
Source: https://tomesphere.com/paper/PMC12796537